The DGCI has approved ZyCoV-D, developed by Zydus Cadila for emergency use in India against the COVID-19 virus. The 3-dose vaccine is said to be 66.6% effective against the virus as per the phase 3 trials. This is the sixth vaccine to be approved by the authorities. The indigenously developed vaccine has become the world's first DNA based vaccine against the COVID-19. It has been cleared for use for those aged 12 and above.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?